Recent Finacing
Recent Raise
Calviri is an ASU Biodesign spinout developing microchip-based displays of >400,000 frameshift peptides to screen anti‑FSP antibodies for cancer vaccines, early-detection diagnostics, and predicting checkpoint inhibitor response.